Advertisement Oxis patented anti-oxidant wins GRAS status - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Oxis patented anti-oxidant wins GRAS status

Oxis International has received a Generally Recognized as Safe (GRAS) status for its patented anti-oxidant - L-ergothioneine.

The company claimed that the body has a specific gene to produce an ergothioneine transporter.

It also claimed that the L-ergothioneine has shown specific promise in extending healthy lifespans, cognitive function, and lung and heart health.

An independent panel of experts reached a decision after a review of the safety, toxicology and proposed usage of Oxis’ synthetic L-ergothioneine that it is safe for use in dietary supplements, food and beverage products.

Oxis CEO David Saloff said achieving GRAS status for their L-ergothioneine opens the door wide to significant new commercial opportunities for the company including the multi-billion dollar market segment for functional foods and beverages.